Race, Ethnicity, and Diffuse Parenchymal Lung Disease

NCT00453713 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 565

Last updated 2015-04-21

No results posted yet for this study

Summary

The purpose of this study is to identify factors that contribute to higher mortality rates among blacks and Hispanics with diffuse parenchymal lung disease.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Columbia University

    lead OTHER

Principal Investigators

  • David J Lederer, M.D. · Columbia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00453713 on ClinicalTrials.gov